About-cancer/treatment/drugs/dexamethasonel/zh

地塞米松

該頁面包含有關地塞米松的簡要信息，以及一些鏈接的鏈接，這些鏈接提供了有關該藥物的使用，研究結果和正在進行的臨床試驗的更多信息。

FDA 批准

是

該藥物的FDA標籤信息可從DailyMed獲得。

用於癌症

地塞米松被批准用於減輕炎症和抑制（降低）人體的免疫反應。

它與其他藥物一起用於治療以下類型的癌症：

• 白血病。

• 淋巴瘤。

• 蕈樣真菌病（一種皮膚T細胞淋巴瘤）。

地塞米松也可單獨使用或與其他藥物一起使用，以預防或治療以下與癌症有關的疾病：

• 貧血。

• 腦水腫 （腦中的液體積聚）與腦瘤有關。

• 藥物超敏反應 （過敏反應）。

• 高鈣血症 （高血鈣水平）。

• 血小板減少症 （低血小板水平）。

地塞米松也可單獨使用或與其他藥物一起用於治療許多其他疾病和狀況。 該藥物繼續用於治療多種類型的癌症和其他疾病。

有關地塞米松的更多信息

NCI藥物詞典中的定義-該藥物的詳細科學定義和其他名稱。

MedlinePlus地塞米松信息-有關該藥物重要信息的通俗易懂的語言摘要，可能包括以下內容：

• 關於這種藥物的警告，

• 這種藥物的用途和用法，

• what you should tell your doctor before using this drug,

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Treatment for Children with Leukemia Also Effective for Adolescents, Young Adults

Three-Drug Combination Extends Survival for Patients with Multiple Myeloma

Three-Drug Combination Benefits Some Patients With Relapsed Multiple Myeloma

Pomalidomide Plus Low-Dose Dexamethasone Improves Survival for Patients With Multiple Myeloma

Clinical Trials Accepting Patients

Find Clinical Trials for Dexamethasone - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.